The average length of stay in Canadian hospitals for patients with malignant neoplasm of the trachea, bronchus, and lung is forecasted to decline steadily from 8.8 days in 2024 to 8.1 days in 2028. In 2023, the average was slightly higher, setting a baseline from which these forecasted reductions are measured. Over the last two years, the year-on-year decrease is approximately 2.3% to 1.2%. The compound annual growth rate (CAGR) over this five-year forecast period reveals an overall decline of about 1.8% per year.
Future trends to monitor include advancements in treatment leading to reduced hospitalization time, improvements in outpatient care, and possible shifts in healthcare policy that could further impact these stays. Keeping an eye on these variables will be essential in anticipating the direction of future changes.
